+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Gastroparesis Drug"

US Gastroparesis Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Gastroparesis Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
From
From
Gastroparesis Disease - Global Clinical Trials Review, H2 2020 - Product Thumbnail Image

Gastroparesis Disease - Global Clinical Trials Review, H2 2020

  • Clinical Trials
  • October 2020
  • 142 Pages
  • Global
From
Diabetic Gastroparesis - Pipeline Review, H2 2020 - Product Thumbnail Image

Diabetic Gastroparesis - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 68 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
Loading Indicator

Gastroparesis Drug is a type of drug used to treat gastroparesis, a condition in which the stomach muscles are weakened and unable to properly move food through the digestive system. These drugs are used to reduce symptoms such as nausea, vomiting, bloating, and abdominal pain. Commonly prescribed drugs for gastroparesis include metoclopramide, domperidone, and erythromycin. Other drugs, such as prokinetics, may also be used to help improve gastric emptying. Gastroparesis Drug is a part of the larger Gastrointestinal Drugs market, which includes drugs used to treat a variety of gastrointestinal conditions. These drugs are used to reduce symptoms, improve digestion, and prevent further complications. Commonly prescribed drugs in this market include antacids, proton pump inhibitors, and laxatives. Some companies in the Gastroparesis Drug market include Novartis, GlaxoSmithKline, Pfizer, and Takeda. Other companies, such as Allergan, Merck, and AstraZeneca, also produce drugs for the treatment of gastroparesis. Show Less Read more